Vulnerability in Fresenius-Kabi Pharmahelp

CVE-2022-45611

An issue was discovered in Fresenius Kabi PharmaHelp 5.1.759.0 allows attackers to gain escalated privileges via via capture of user login information.

Published · last modified .

CVSS v3 metric

CVSS v3 base score 9.8 (Critical). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H.

EPSS exploit prediction

EPSS: 0.012 (66.5th percentile), scored .

Low probability of exploitation in the next 30 days, but still tracked. 66th percentile — 66.5% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-45611: held from 0.012 to 0.012.

EPSS over last 30 days · oldest: 0.012 · newest: 0.012 · change: 0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-45611?
CVE-2022-45611 is a critical-severity vulnerability in Fresenius-Kabi Pharmahelp, classified under Insufficiently Protected Credentials. CVSS score: 9.8/10. Published 2023-08-22.
How severe is CVE-2022-45611?
Critical severity. CVSS v3 base score is 9.8 out of 10.